Literature DB >> 9191951

9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.

J J Bourguignon1, L Désaubry, P Raboisson, C G Wermuth, C Lugnier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9191951     DOI： 10.1021/jm960827x

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

1.  Inhibition of cAMP-phosphodiesterase 4 (PDE4) potentiates the anesthetic effects of Isoflurane in mice.

Authors:  Ileana V Aragon; Abigail Boyd; Lina Abou Saleh; Justin Rich; Will McDonough; Anna Koloteva; Wito Richter
Journal:  Biochem Pharmacol       Date:  2021-02-18       Impact factor: 5.858

2.  Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.

Authors:  Thérèse Keravis; Fanny Monneaux; Issaka Yougbaré; Lucien Gazi; Jean-Jacques Bourguignon; Sylviane Muller; Claire Lugnier
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

Review 3.  PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking.

Authors:  Claire Lugnier; Hayder M Al-Kuraishy; Eric Rousseau
Journal:  Biochem Pharmacol       Date:  2021-01-28       Impact factor: 6.100
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.